Cargando…

Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias

Detalles Bibliográficos
Autores principales:	Issa, Hasan, Bhayadia, Raj, Winkler, Robert, Swart, Laura Elise, Heckl, Dirk, Klusmann, Jan-Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317836/ https://www.ncbi.nlm.nih.gov/pubmed/37311946 http://dx.doi.org/10.1038/s41375-023-01937-6

Ejemplares similares

P419: HARNESSING MIRNA-193B-3P MIMIC AS A POTENT THERAPEUTIC OPTION IN ACUTE MYELOID LEUKEMIA
por: Issa, Hasan, et al.
Publicado: (2023)

P467: LONG NON-CODING RNA SNHG29 IS A NOVEL MYELOID LEUKEMIA DEPENDENCY
por: Winkler, Robert, et al.
Publicado: (2023)

Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
por: Grimm, Juliane, et al.
Publicado: (2022)

Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15
por: Ng, Michelle, et al.
Publicado: (2023)

The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia
por: Ng, Michelle, et al.
Publicado: (2019)

PB1788: A SCREENING OF DONATED CHEMICAL PROBES TO IDENTIFY NOVEL THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML) IN CHILDHOOD
por: Laszig, Stephanie, et al.
Publicado: (2023)

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022)

PB1813: REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA
por: Verboon, Lonneke, et al.
Publicado: (2023)

PB1825: IDENTIFYING GENE TARGETS FOR DRUG REPURPOSING TO COUNTER MYELOID LEUKEMIA IN CHILDREN WITH DOWN-SYNDROME (ML-DS)
por: Schmell, Anna-Lena, et al.
Publicado: (2023)

P422: TARGETING THE WT1MUT-MIR-193A TRANSCRIPTIONAL AXIS WITH INT-1B3, A NOVEL LIPID NANOPARTICLE-FORMULATED MIR-193A-3P MIMIC IN ACUTE MYELOID LEUKEMIA
por: Yang, Xining, et al.
Publicado: (2023)

RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia
por: Gialesaki, Sofia, et al.
Publicado: (2023)

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
por: Grimm, Juliane, et al.
Publicado: (2021)

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis
por: Alejo-Valle, Oriol, et al.
Publicado: (2022)

RNA-Binding Proteins in Acute Leukemias
por: Schuschel, Konstantin, et al.
Publicado: (2020)

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
por: Obulkasim, Askar, et al.
Publicado: (2017)

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia
por: Lim, Byungho, et al.
Publicado: (2022)

miRNAs in acute myeloid leukemia
por: Liao, Qiong, et al.
Publicado: (2016)

CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
por: Reimer, Jana, et al.
Publicado: (2017)

Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia
por: Muhowski, Elizabeth M., et al.
Publicado: (2022)

Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics
por: Hashemi, Zahra Sadat, et al.
Publicado: (2018)

Acute Myeloid Leukemia Masquerading as Acute Appendicitis
por: Shen, Kai, et al.
Publicado: (2017)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Integrative molecular subtypes of acute myeloid leukemia
por: Mo, Qianxing, et al.
Publicado: (2023)

Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)

Myxoma Mimic in a Patient With Acute Myeloid Leukemia
por: Campo-Rivera, Natalia, et al.
Publicado: (2023)

Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020)

Orthodontic treatment for a patient with acute myeloid leukemia
por: Hsin-Chung Cheng, Johnson, et al.
Publicado: (2022)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

Molecular predictors of post-transplant survival in acute myeloid leukemia
por: Qin, Tong, et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

The clinical impact of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2023)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
por: Maiti, Abhishek, et al.
Publicado: (2021)

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
por: Krakowsky, Rosanna H. E., et al.
Publicado: (2018)

Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
por: Maung, Kyaw Ze Ya, et al.
Publicado: (2018)

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia
por: Goswami, Meghali, et al.
Publicado: (2020)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Identification of a novel NPM1 mutation in acute myeloid leukemia
por: Yao, Yiyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fk2acekcj96uknjj9q9au6t31j